days after receiving parental spleen cells, the Fl-tumour-bearing mice were killed and their spleen ratios and indices were determined as an index of the severity of the graft -versus -host reaction (GvHR) induced. The spleen indices were compared with those in non-tumour-bearing F1 mice, receiving aliquots of the same parental cell suspensions. At the higher doses of A spleen cells, the presence of an F1 tumour reduced the GvHR. At the same time, in 3/5 experiments, the weight of the F1 tumour in mice injected with immune A spleen cells was less than that in F1 mice receiving the same number of tumour cells but no spleen cells. A reduction in GvHR and a decrease in tumour weight was not seen when F1 mice carrying an A strain tumour were injected with A strain spleen cells immune to an F1 tumour. Adding 23-day F1 tumour-bearing F1 spleen cells to A spleen cells did not reduce the GvHR induced in further non-tumour-bearing F1 recipients by the parental cells. This was evidence against the presence of suppressor cells in the tumour-bearing F1 spleen.
When 51Cr-labelled A strain spleen cells were injected into F1 mice, some of which had a tumour and therefore an enlarged spleen, there was an inverse relation between the size of the spleen and the number of parental cells therein, per g spleen 4 h after injection.
It is thus suggested that the reduction in GvHR in Fl-tumour-bearing F1 mice, after injection of parental spleen cells, is due first to a reduction in the concentration of donor cells in the recipient spleen (i.e. the same number of donor cells in a larger spleen) and second to pre-occupation of the donor cells in reacting to the tumour.
THERE HAVE BEEN a number of reports that injection of parental immunologically competent cells (ICC) into F1 hybrid mice will inhibit the growth of tumours transplanted to these animals. There are two categories of this phenomenon, depending on whether the ICC are injected before or after tumour transplantation. Wigzell (1961) splenomegaly and an increased phagocytic index followed a similar time course. The spleen index for each animal was the quotient individual spleen ratio/mean control spleen ratio. The denominator was the mean for non-tumour-bearing or tumour-bearing mice as appropriate. In most experiments, the presence of a tumour itself induced splenomegaly (Woodruff & Symes, 1962) and this had to be considered in evaluating the increase in spleen weight due to the induction of a GvHR. Sample calculations are presented in Table I .
Irradiation of mice.-This was given using a 4kCi 137Cs source of y-rays at an FSD of 60 cm. The dose rate was 0 9 rad/s. 51Cr labelling of spleen cells-.Spleen-cell suspensions were prepared as described above and the contaminating erythrocytes were lysed using tris-buffered NH4Cl (Boyle, 1968 (Table II) . In Expt 2, the findings were similar, the presence of a tumour causing a significantly lower spleen index in F1 animals receiving either 5, 10 or 15 x 107 tumourimmune parental spleen cells (Table II) . spleen cells on Day 9. Similar doses of A spleen cells from the same cell suspension were injected into separate groups of nontumour-bearing F1 mice. All the A strain donor mice had received 1-8 x 106 F1 tumour cells i.p. 9 days before harvesting their spleens, in order to immunize against the CBA component of the F1. All normal and tumour-bearing F1 mice receiving spleen cells were killed 14 days later and their spleen indices were determined.
The presence of a tumour did not reduce the GvHR induced by any of the doses of parental spleen cells injected (Table IV) . The weight of the tumour, in F1 mice, 14 days after injection of parental spleen cells, was determined in Expts 1-6. In 3 of the 5 experiments 1-5, where the tumour was of F1 genotype, animals receiving 108 spleen cells i.v. showed a significantly smaller tumour than tumourbearing animals into which parental ICC had not been injected (Table IV) .
Injection of A strain spleen cells into F1 mice bearing A strain tumours, did not reduce the tumour size (Expt 6, Table IV) .
Thus, in Expts 3-5, reduction in the GvHR induced by parental spleen cells injected into tumour-bearing F1 mice was associated with a reduction in the size of the F1 tumour. This suggested that the reaction of the spleen cells against the tumour may have contributed to a reduction in the GvHR induced. It may be seen from Table VI that F1 spleen cells from tumour-bearing animals did not reduce the GvHR induced by admixed A spleen cells. Thus, no evidence of a suppressor-cell population in the spleens of Fl-tumour-bearing F1 mice could be found by adoptive cell transfer. However, it might be argued that the intact spleen did not allow adequate "space" for the proliferation of any potential F1 suppressor cells. As a variant of this experiment (Expt 10) normal F1 mice, which had received 3 Gy whole-body irradiation 24 h before, served as recipients for the cell mixtures. As may be seen from Table VI , when the same cell mixtures as were transferred into unirradiated F1 recipients (Expt 9) were injected into irradiated recipients (Expt 10), a reduction in GvHR was obtained, on admixture of A spleen cells with both normal and tumour-bearing F1 spleen cells. However, the reduction of GvHR was not due to the presence of suppressor cells as there was no significant difference in spleen index between mice receiving normal and tumour-bearing F1 spleen. It is therefore suggested that in the irradiated recipient there is more space for the transferred F1 cells to proliferate, and that this competition for space inhibits the multiplication of A spleen cells and hence the degree of GvHR induced.
The distribution of 51Cr-labelled A spleen cells in normal and tumour-bearing F1 mice 108 A strain spleen cells (from donors immunized 9 days before against F1 (Fox, 1962 It is possible that the different cell populations in the spleens of normal and tumour-bearing mice, might render the latter animals less susceptible to induction of GvHR. However, the spleens of both tumour-bearing mice (Woodruff & Symes, 1962) and mice in the proliferative phase of a GvHR (Howard, 1961) show similar histological pictures; in both there is proliferation of plasma cells and their precursors in the red pulp. Fujimoto et al. (1976) showed that the spleens of tumour-bearing mice contained suppressor cells, which, on adoptive transfer to syngeneic tumour-immune mice, could block tumour rejection. It was thus possible that the parental spleen cells, inducing GvHR, might be suppressed by the presence of a tumour in the recipient F1. Expts 7-9, in which spleen cells from tumour-bearing F1 mice and A spleen cells were mixed prior to adoptive transfer to further normal F1 mice, failed to demonstrate suppressor cells in the F1 mice with tumours. The absence of suppressor cells in those mice is also suggested by the ability of injected A spleen cells to retard the growth of a tumour in the F1 recipients. Furthermore, Rees & Symes (1971) found no difference in the ability of A spleen cells from normal and tumour-bearing mice to induce GvHR on injection into F1 recipients.
WHITAIARSH-EVERISS AND
Animals with an ongoing GvHR retarded the growth of a subsequently transplanted neoplasm. This was ascribed to host "immunopotentiation" (Osborne & Katz, 1977) . However, such a phenomenon is unlikely to explain the reduction in GvHR described in the present paper, as the GvHR was not reduced when an A strain tumour was present in the F1 receiving A spleen cells.
The idea that a tumour may deflect the immune response of foreign ICC to itself, with consequent protection of the host against GvHR may stimulate attempts to treat neoplasms by adoptive transfer of foreign immunologically competent cells.
